{"id":9127,"date":"2024-12-11T23:07:59","date_gmt":"2024-12-12T04:07:59","guid":{"rendered":"https:\/\/type1support.ca\/discontinuation-of-certain-types-of-insulin\/"},"modified":"2025-10-22T08:33:09","modified_gmt":"2025-10-22T12:33:09","slug":"discontinuation-of-certain-types-of-insulin","status":"publish","type":"post","link":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/","title":{"rendered":"Discontinuation of certain types of insulin"},"content":{"rendered":"<p>Novo Nordisk announced, in early October 2024, that it would soon cease the production and marketing of some products\u2014including several types of insulin\u2014from its diabetes product line-up.<\/p>\n<p>The decision was not made due to safety or quality issues, but rather to business considerations that mainly affect specific formats of older injectable drugs for which there are often newer alternatives.<\/p>\n<h2><b>Which products will be affected in Canada?<\/b><\/h2>\n<p>Within the next year or two, seven products will be withdrawn from the Canadian market. This should have little impact on most people with type 1 diabetes (T1D). Nevertheless, here are the dates to keep in mind, as well as the proposed alternatives to discontinued items.<\/p>\n<h3 style=\"padding-left: 40px;\">1. Fiasp\u00ae FlexTouch\u00ae 3\u00a0ml pre-filled pen<\/h3>\n<ul>\n<li>Expected withdrawal date: December 2025.<\/li>\n<li>Recommended alternatives: Fiasp\u00ae PenFill\u00ae 3 ml cartridge.<\/li>\n<li>Possible impacts: you\u2019ll need a NovoPen reusable pen compatible with Fiasp\u00ae PenFill cartridges.<\/li>\n<\/ul>\n<h3 style=\"padding-left: 40px;\">2. Levemir\u00ae PenFill\u00ae 3\u00a0ml cartridge<\/h3>\n<ul>\n<li>Expected withdrawal date: December 2025.<\/li>\n<\/ul>\n<ul>\n<li>Recommended alternatives:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Awiqli\u00ae (insulin icodec) FlexTouch\u00ae 700 U\/ml (1.5\u00a0ml, 3\u00a0ml) pen<\/li>\n<li>U100 injectable insulin glargine solution (Basalgar\u00ae, Lantus\u00ae, SemGlee\u00ae)<\/li>\n<li>Humulin\u00ae N cartridge, vial or KwikPen\u00ae<\/li>\n<li>Novolin\u00ae NPH\u00a010\u00a0ml vial<\/li>\n<li>Toujeo\u00ae (glargine U300) pre-filled pen<\/li>\n<li>Tresiba\u00ae (insulin degludec) pre-filled pen<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Possible impacts: little impact. Levemir\u00ae PenFill\u00ae insulin is rarely used in the treatment of T1D.<\/li>\n<\/ul>\n<h3 style=\"padding-left: 40px;\">3. Novolin\u00aege Toronto PenFill\u00ae 3\u00a0ml cartridge<\/h3>\n<ul>\n<li>Expected withdrawal date: December 2025.<\/li>\n<\/ul>\n<ul>\n<li>Recommended alternatives:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Humulin\u00ae R cartridge or KwikPen\u00ae<\/li>\n<li>Humulin\u00ae R vial<\/li>\n<li>Novolin\u00aege Toronto\u00a010\u00a0ml vial<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Possible impacts: little impact. Novolin\u00aege Toronto PenFill\u00ae insulin is rarely used in the treatment of T1D. In most cases, insulin aspart (Trurapi\u00ae), insulin lispro (Admelog\u00ae), insulin guilisine (Apidra\u00ae) or Fiasp\u00ae are prioritized.<\/li>\n<\/ul>\n<h3 style=\"padding-left: 40px;\">4. Novolin\u00aege 30\/70 PenFill\u00ae 3\u00a0ml cartridge<\/h3>\n<ul>\n<li>Expected withdrawal date: December 2025.<\/li>\n<\/ul>\n<ul>\n<li>Recommended alternatives:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Humulin\u00ae 30\/70 cartridge<\/li>\n<li>Novolin\u00aege 30\/70 10\u00a0ml vial<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Possible impacts: little impact. These products are rarely used in the treatment of T1D.<\/li>\n<\/ul>\n<h3 style=\"padding-left: 40px;\">5. Novolin\u00aege NPH PenFill\u00ae 3\u00a0ml cartridge<\/h3>\n<ul>\n<li>Expected withdrawal date: December 2025.<\/li>\n<\/ul>\n<ul>\n<li>Recommended alternatives:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Humulin\u00ae N cartridge, vial or KwikPen\u00ae<\/li>\n<li>Novolin\u00aege NPH\u00a010\u00a0ml vial<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Possible impacts: little impact. These products are rarely used in the treatment of T1D.<\/li>\n<\/ul>\n<h3 style=\"padding-left: 40px;\">6. 3 ml pre-filled pen Victoza\u00ae<\/h3>\n<ul>\n<li>Expected withdrawal date: March 2026.<\/li>\n<\/ul>\n<ul>\n<li>Recommended alternatives: 0ther similar injectable molecules marketed for weight loss and glycemic control. Examples: Ozempic\u00ae, Trulicity\u00ae, Moujaro\u00ae, Rybelsus\u00ae.<\/li>\n<\/ul>\n<ul>\n<li>Possible impacts: little impact. These molecules are not authorized for use in the treatment of T1D. However, data from the <a href=\"https:\/\/type1better.com\/en\/the-better-project\/the-better-registry\/\">BETTER registry<\/a> indicate that around 5% of participants use them in combination with insulin to improve glycemic control. If you are affected, discuss your options with your healthcare team.<\/li>\n<\/ul>\n<h3 style=\"padding-left: 40px;\">7. 3 ml pre-filled pen Xultophy\u00ae<\/h3>\n<ul>\n<li>Expected withdrawal date: December 2025.<\/li>\n<\/ul>\n<ul>\n<li>Recommended alternatives:\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li>Soliqua\u00ae pre-filled pen<\/li>\n<li>Free combination of other molecules marketed for weight loss and glycemic control.<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<ul>\n<li>Possible impacts:\u00a0Soliqua\u00ae, which combines insulin degludec (Tresiba\u00ae) with semaglutide (Ozempic\u00ae), is not authorized for use in the treatment of T1D. Our data indicate that it is used exceptionally by <a href=\"https:\/\/type1better.com\/en\/the-better-project\/the-better-registry\/\">BETTER registry<\/a> participants.<\/li>\n<\/ul>\n<h2><b>Do you need to change your treatment? Discuss the next steps to take with your healthcare team.<\/b><\/h2>\n<p>If you currently use any products expected to be discontinued, don\u2019t hesitate to discuss alternatives with your healthcare team now.<\/p>\n<p>Clinical experience shows that it is preferable (and more reassuring) to change treatment well before its discontinuation. During the transition, it\u2019s essential to carefully monitor your blood sugar levels to adapt the new treatment to your needs.<\/p>\n<blockquote><p>To find out more about the different types of insulin and their modes of action, see our <a href=\"https:\/\/type1better.com\/wp-content\/uploads\/2022\/04\/Insulin-modes-of-action.pdf\">Insulin modes of action<\/a> guide.<\/p><\/blockquote>\n<p><strong>Written by: <\/strong>Nathalie Kinnard, scientific writer and research assistant<\/p>\n<p><strong>Reviewed by:<br \/>\n<\/strong><\/p>\n<ul>\n<li>R\u00e9mi Rabasa-Lhoret, MD, Ph.D.<\/li>\n<li>Sarah Haag, R.N., B.Sc.<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Novo Nordisk announced, in early October 2024, that it would soon cease the production and marketing of some products\u2014including several types of insulin\u2014from its diabetes product line-up. The decision was not made due to safety or quality issues, but rather to business considerations that mainly affect specific formats of older injectable drugs for which there [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":8202,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_bbp_topic_count":0,"_bbp_reply_count":0,"_bbp_total_topic_count":0,"_bbp_total_reply_count":0,"_bbp_voice_count":0,"_bbp_anonymous_reply_count":0,"_bbp_topic_count_hidden":0,"_bbp_reply_count_hidden":0,"_bbp_forum_subforum_count":0,"footnotes":""},"categories":[4262],"tags":[4264],"class_list":["post-9127","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medication-2","tag-articles-fr","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Discontinuation of certain types of insulin - Support<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Discontinuation of certain types of insulin - Support\" \/>\n<meta property=\"og:description\" content=\"Novo Nordisk announced, in early October 2024, that it would soon cease the production and marketing of some products\u2014including several types of insulin\u2014from its diabetes product line-up. The decision was not made due to safety or quality issues, but rather to business considerations that mainly affect specific formats of older injectable drugs for which there [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/\" \/>\n<meta property=\"og:site_name\" content=\"Support\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-12T04:07:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-22T12:33:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/type1support.naracreative.com\/wp-content\/uploads\/2025\/06\/arret-insuline.png\" \/>\n\t<meta property=\"og:image:width\" content=\"2100\" \/>\n\t<meta property=\"og:image:height\" content=\"1013\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Nara Creative\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nara Creative\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/\"},\"author\":{\"name\":\"Nara Creative\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#\\\/schema\\\/person\\\/2ff051523d648b019cff3909cdc91593\"},\"headline\":\"Discontinuation of certain types of insulin\",\"datePublished\":\"2024-12-12T04:07:59+00:00\",\"dateModified\":\"2025-10-22T12:33:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/\"},\"wordCount\":595,\"publisher\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/type1support.naracreative.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/arret-insuline.png\",\"keywords\":[\"Articles\"],\"articleSection\":[\"Medication\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/\",\"url\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/\",\"name\":\"Discontinuation of certain types of insulin - Support\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/type1support.naracreative.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/arret-insuline.png\",\"datePublished\":\"2024-12-12T04:07:59+00:00\",\"dateModified\":\"2025-10-22T12:33:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/#primaryimage\",\"url\":\"https:\\\/\\\/type1support.naracreative.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/arret-insuline.png\",\"contentUrl\":\"https:\\\/\\\/type1support.naracreative.com\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/arret-insuline.png\",\"width\":2100,\"height\":1013},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/discontinuation-of-certain-types-of-insulin\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/type1support.naracreative.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Discontinuation of certain types of insulin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#website\",\"url\":\"https:\\\/\\\/type1support.naracreative.com\\\/\",\"name\":\"Type1Support\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/type1support.naracreative.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#organization\",\"name\":\"Type1Support\",\"url\":\"https:\\\/\\\/type1support.naracreative.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/type1support.ca\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_support.png\",\"contentUrl\":\"https:\\\/\\\/type1support.ca\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/logo_support.png\",\"width\":253,\"height\":64,\"caption\":\"Type1Support\"},\"image\":{\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/type1support.naracreative.com\\\/#\\\/schema\\\/person\\\/2ff051523d648b019cff3909cdc91593\",\"name\":\"Nara Creative\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac453aae22aac79921ce5c9ff996f107abb65201217b31ffff4cca5d135a287d?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac453aae22aac79921ce5c9ff996f107abb65201217b31ffff4cca5d135a287d?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/ac453aae22aac79921ce5c9ff996f107abb65201217b31ffff4cca5d135a287d?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g\",\"caption\":\"Nara Creative\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Discontinuation of certain types of insulin - Support","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Discontinuation of certain types of insulin - Support","og_description":"Novo Nordisk announced, in early October 2024, that it would soon cease the production and marketing of some products\u2014including several types of insulin\u2014from its diabetes product line-up. The decision was not made due to safety or quality issues, but rather to business considerations that mainly affect specific formats of older injectable drugs for which there [&hellip;]","og_url":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/","og_site_name":"Support","article_published_time":"2024-12-12T04:07:59+00:00","article_modified_time":"2025-10-22T12:33:09+00:00","og_image":[{"width":2100,"height":1013,"url":"https:\/\/type1support.naracreative.com\/wp-content\/uploads\/2025\/06\/arret-insuline.png","type":"image\/png"}],"author":"Nara Creative","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nara Creative","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/#article","isPartOf":{"@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/"},"author":{"name":"Nara Creative","@id":"https:\/\/type1support.naracreative.com\/#\/schema\/person\/2ff051523d648b019cff3909cdc91593"},"headline":"Discontinuation of certain types of insulin","datePublished":"2024-12-12T04:07:59+00:00","dateModified":"2025-10-22T12:33:09+00:00","mainEntityOfPage":{"@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/"},"wordCount":595,"publisher":{"@id":"https:\/\/type1support.naracreative.com\/#organization"},"image":{"@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/#primaryimage"},"thumbnailUrl":"https:\/\/type1support.naracreative.com\/wp-content\/uploads\/2025\/06\/arret-insuline.png","keywords":["Articles"],"articleSection":["Medication"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/","url":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/","name":"Discontinuation of certain types of insulin - Support","isPartOf":{"@id":"https:\/\/type1support.naracreative.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/#primaryimage"},"image":{"@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/#primaryimage"},"thumbnailUrl":"https:\/\/type1support.naracreative.com\/wp-content\/uploads\/2025\/06\/arret-insuline.png","datePublished":"2024-12-12T04:07:59+00:00","dateModified":"2025-10-22T12:33:09+00:00","breadcrumb":{"@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/#primaryimage","url":"https:\/\/type1support.naracreative.com\/wp-content\/uploads\/2025\/06\/arret-insuline.png","contentUrl":"https:\/\/type1support.naracreative.com\/wp-content\/uploads\/2025\/06\/arret-insuline.png","width":2100,"height":1013},{"@type":"BreadcrumbList","@id":"https:\/\/type1support.naracreative.com\/en\/discontinuation-of-certain-types-of-insulin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/type1support.naracreative.com\/en\/"},{"@type":"ListItem","position":2,"name":"Discontinuation of certain types of insulin"}]},{"@type":"WebSite","@id":"https:\/\/type1support.naracreative.com\/#website","url":"https:\/\/type1support.naracreative.com\/","name":"Type1Support","description":"","publisher":{"@id":"https:\/\/type1support.naracreative.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/type1support.naracreative.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/type1support.naracreative.com\/#organization","name":"Type1Support","url":"https:\/\/type1support.naracreative.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/type1support.naracreative.com\/#\/schema\/logo\/image\/","url":"https:\/\/type1support.ca\/wp-content\/uploads\/2025\/03\/logo_support.png","contentUrl":"https:\/\/type1support.ca\/wp-content\/uploads\/2025\/03\/logo_support.png","width":253,"height":64,"caption":"Type1Support"},"image":{"@id":"https:\/\/type1support.naracreative.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/type1support.naracreative.com\/#\/schema\/person\/2ff051523d648b019cff3909cdc91593","name":"Nara Creative","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/ac453aae22aac79921ce5c9ff996f107abb65201217b31ffff4cca5d135a287d?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/ac453aae22aac79921ce5c9ff996f107abb65201217b31ffff4cca5d135a287d?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ac453aae22aac79921ce5c9ff996f107abb65201217b31ffff4cca5d135a287d?s=96&d=https%3A%2F%2Ftype1support.ca%2Fdev%2Fwp-content%2Fuploads%2F2019%2F09%2Fapple.png&r=g","caption":"Nara Creative"}}]}},"category_colors":{"4262":"#5cdedf"},"_links":{"self":[{"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/posts\/9127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/comments?post=9127"}],"version-history":[{"count":0,"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/posts\/9127\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/media\/8202"}],"wp:attachment":[{"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/media?parent=9127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/categories?post=9127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/type1support.naracreative.com\/en\/wp-json\/wp\/v2\/tags?post=9127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}